A nationwide wastewater-based assessment of metformin consumption across Australia

Metformin is the most widely used drug to treat type 2 diabetes. Monitoring spatial patterns of metformin use could provide new insights into treatment of type 2 diabetes and the distribution among populations. This study applied a wastewater-based epidemiological (WBE) approach to estimate metformi...

Full description

Bibliographic Details
Main Authors: Dan Yang, Qiuda Zheng, Phong K. Thai, Fahad Ahmed, Jake W. O'Brien, Jochen F. Mueller, Kevin V. Thomas, Ben Tscharke
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Environment International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0160412022002094
_version_ 1818555639649009664
author Dan Yang
Qiuda Zheng
Phong K. Thai
Fahad Ahmed
Jake W. O'Brien
Jochen F. Mueller
Kevin V. Thomas
Ben Tscharke
author_facet Dan Yang
Qiuda Zheng
Phong K. Thai
Fahad Ahmed
Jake W. O'Brien
Jochen F. Mueller
Kevin V. Thomas
Ben Tscharke
author_sort Dan Yang
collection DOAJ
description Metformin is the most widely used drug to treat type 2 diabetes. Monitoring spatial patterns of metformin use could provide new insights into treatment of type 2 diabetes and the distribution among populations. This study applied a wastewater-based epidemiological (WBE) approach to estimate metformin use in different populations across Australia and compared these estimates with traditional approaches of surveys and prescription data. Twenty-four-hour influent samples were collected from 75 wastewater treatment plants (WWTPs) across Australia in 2016 and analysed for metformin. Metformin was detected in all samples ranging in concentration from 8.2 to 191 µg/L (median 58 µg/L). Concentrations were converted to population-weighted average consumption at the national level, resulting in an average consumption of 28.6 g/day/1000 people across Australia, which was within 7% of estimates from national prescription statistics. In addition, results for five out of seven states had an estimated prevalence of type 2 diabetes within 20% compared to the traditional epidemiology surveys. Spatial patterns were also observed between urban and rural settings, with higher consumption rates of metformin found in Major Cities (22.5 ± 10.9 g/d/1000 people) and Inner Regional cities (25.4 ± 13.4 g/d/1000 people) than in Outer Regional (17.0 ± 8.1 g/d/1000 people) and Remote areas (15.1 ± 7.4 g/d/1000 people). Consumption estimates were also correlated against socioeconomic factors of the specific catchment areas. Greater metformin use was correlated with populations of lower education and income levels, while positive correlations were found between metformin consumption and consumption of allopurinol, caffeine and venlafaxine. Our study provides more evidence on the distribution of metformin use across Australia, which can be used to develop public health strategies to reduce the overall burden of type 2 diabetes in specific regions.
first_indexed 2024-12-12T09:56:15Z
format Article
id doaj.art-d6f94ba756424440a1187ad633a79b7a
institution Directory Open Access Journal
issn 0160-4120
language English
last_indexed 2024-12-12T09:56:15Z
publishDate 2022-07-01
publisher Elsevier
record_format Article
series Environment International
spelling doaj.art-d6f94ba756424440a1187ad633a79b7a2022-12-22T00:28:08ZengElsevierEnvironment International0160-41202022-07-01165107282A nationwide wastewater-based assessment of metformin consumption across AustraliaDan Yang0Qiuda Zheng1Phong K. Thai2Fahad Ahmed3Jake W. O'Brien4Jochen F. Mueller5Kevin V. Thomas6Ben Tscharke7Queensland Alliance for Environmental Health Sciences (QAEHS), The University of Queensland, 20 Cornwall Street, Woolloongabba, Queensland 4102, Australia; Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing 400030, ChinaQueensland Alliance for Environmental Health Sciences (QAEHS), The University of Queensland, 20 Cornwall Street, Woolloongabba, Queensland 4102, Australia; Corresponding author.Queensland Alliance for Environmental Health Sciences (QAEHS), The University of Queensland, 20 Cornwall Street, Woolloongabba, Queensland 4102, AustraliaQueensland Alliance for Environmental Health Sciences (QAEHS), The University of Queensland, 20 Cornwall Street, Woolloongabba, Queensland 4102, AustraliaQueensland Alliance for Environmental Health Sciences (QAEHS), The University of Queensland, 20 Cornwall Street, Woolloongabba, Queensland 4102, AustraliaQueensland Alliance for Environmental Health Sciences (QAEHS), The University of Queensland, 20 Cornwall Street, Woolloongabba, Queensland 4102, AustraliaQueensland Alliance for Environmental Health Sciences (QAEHS), The University of Queensland, 20 Cornwall Street, Woolloongabba, Queensland 4102, AustraliaQueensland Alliance for Environmental Health Sciences (QAEHS), The University of Queensland, 20 Cornwall Street, Woolloongabba, Queensland 4102, AustraliaMetformin is the most widely used drug to treat type 2 diabetes. Monitoring spatial patterns of metformin use could provide new insights into treatment of type 2 diabetes and the distribution among populations. This study applied a wastewater-based epidemiological (WBE) approach to estimate metformin use in different populations across Australia and compared these estimates with traditional approaches of surveys and prescription data. Twenty-four-hour influent samples were collected from 75 wastewater treatment plants (WWTPs) across Australia in 2016 and analysed for metformin. Metformin was detected in all samples ranging in concentration from 8.2 to 191 µg/L (median 58 µg/L). Concentrations were converted to population-weighted average consumption at the national level, resulting in an average consumption of 28.6 g/day/1000 people across Australia, which was within 7% of estimates from national prescription statistics. In addition, results for five out of seven states had an estimated prevalence of type 2 diabetes within 20% compared to the traditional epidemiology surveys. Spatial patterns were also observed between urban and rural settings, with higher consumption rates of metformin found in Major Cities (22.5 ± 10.9 g/d/1000 people) and Inner Regional cities (25.4 ± 13.4 g/d/1000 people) than in Outer Regional (17.0 ± 8.1 g/d/1000 people) and Remote areas (15.1 ± 7.4 g/d/1000 people). Consumption estimates were also correlated against socioeconomic factors of the specific catchment areas. Greater metformin use was correlated with populations of lower education and income levels, while positive correlations were found between metformin consumption and consumption of allopurinol, caffeine and venlafaxine. Our study provides more evidence on the distribution of metformin use across Australia, which can be used to develop public health strategies to reduce the overall burden of type 2 diabetes in specific regions.http://www.sciencedirect.com/science/article/pii/S0160412022002094WastewaterMetforminType 2 diabetesSocio-economic factorsSpatial pattern
spellingShingle Dan Yang
Qiuda Zheng
Phong K. Thai
Fahad Ahmed
Jake W. O'Brien
Jochen F. Mueller
Kevin V. Thomas
Ben Tscharke
A nationwide wastewater-based assessment of metformin consumption across Australia
Environment International
Wastewater
Metformin
Type 2 diabetes
Socio-economic factors
Spatial pattern
title A nationwide wastewater-based assessment of metformin consumption across Australia
title_full A nationwide wastewater-based assessment of metformin consumption across Australia
title_fullStr A nationwide wastewater-based assessment of metformin consumption across Australia
title_full_unstemmed A nationwide wastewater-based assessment of metformin consumption across Australia
title_short A nationwide wastewater-based assessment of metformin consumption across Australia
title_sort nationwide wastewater based assessment of metformin consumption across australia
topic Wastewater
Metformin
Type 2 diabetes
Socio-economic factors
Spatial pattern
url http://www.sciencedirect.com/science/article/pii/S0160412022002094
work_keys_str_mv AT danyang anationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia
AT qiudazheng anationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia
AT phongkthai anationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia
AT fahadahmed anationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia
AT jakewobrien anationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia
AT jochenfmueller anationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia
AT kevinvthomas anationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia
AT bentscharke anationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia
AT danyang nationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia
AT qiudazheng nationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia
AT phongkthai nationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia
AT fahadahmed nationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia
AT jakewobrien nationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia
AT jochenfmueller nationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia
AT kevinvthomas nationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia
AT bentscharke nationwidewastewaterbasedassessmentofmetforminconsumptionacrossaustralia